Use of ceragenins as a potential treatment for urinary tract infections.

Urszula WnorowskaEwelina PiktelBonita DurnaśKrzysztof FiedorukPaul B SavageRobert Bucki

Published in: BMC infectious diseases (2019)

We suggest that the employment of combination of natural peptide LL-37 with synthetic analogs might be a potential solution to treat urinary tract infections caused by drug-resistant bacteria.

Keyphrases

urinary tract infection
drug resistant
multidrug resistant
acinetobacter baumannii
human health
risk assessment